<DOC>
	<DOCNO>NCT01043679</DOCNO>
	<brief_summary>The goal research evaluate safety well effectiveness Utapine Seroquel bipolar I disorder patient .</brief_summary>
	<brief_title>Efficacy Safety Utapine vs. Seroquel Patients With Bipolar Mania</brief_title>
	<detailed_description>Utapine Serquel belong anti-bipolar medication family , approve DOH ( Department Health , Taiwan ) , ingredient different manufacture . From clinical trial report , excellent effectiveness safety . The goal research evaluate safety well effectiveness Utapine Seroquel bipolar I disorder patient different ingredient different manufacture .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>1 . Male female age 1865 year diagnosis bipolar I disorder include DSMIV criterion make least one manic mixepisode record study entry . 2 . Having minimum score 20 Young Mania Rating Scale ( YMRS ) , plus score least 4 two core YMRS item Irritability , Speech , Content , Disruptive/Aggressive Behavior . 3 . At least 4 Severity Illness item Clinical Global ImpressionsNBipolar ( CGINBP ) assessment tool . 4 . Patient good compliance study medicine adherence study protocol . 1 . Had receive treatment clozapine within 28 day start trial . 2 . Had hospitalise 3 week longer index manic episode . 3 . DSMIV criterion rapid cycle current mixed episode . 4 . Intolerance lack response quetiapine clozapine trial diagnose investigator . 5 . Neurodegenerative disease eg : Parkinson desease、Huntington disease、Pick 's disease . 6 . Medicine drug change mental condition judge investigator . 7 . EKG abnormality 8 . Drug alcohol abuser</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Bipolar , Mania</keyword>
	<keyword>Utapine</keyword>
	<keyword>Seroquel</keyword>
</DOC>